Elhízás: vizsgálatok itt: Izrael

In Izrael 19 Also abroad 1939

19 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Holon, Jerusalem, Kfar Saba, Petah Tikva, Tel Aviv
Életkor
18 év and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
3. fázisTaking people
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Where
Beersheba, Beer Yaacov, Haifa, Jerusalem, Petah Tikva, Ramat Gan
Életkor
6 év to 17 év
People
125 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06672549
3. fázisTaking people
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Where
Beer Jacob, Jerusalem, Ramat Gan
Életkor
12 év to 17 év
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06672939 · EU 2024-514081-40-00
3. fázisTaking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Ashdod, Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv, Tsrifin
Életkor
18 év to 70 év
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
3. fázisTaking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Ashdod, Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv, Tsrifin
Életkor
18 év to 70 év
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
3. fázisTaking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
Afula, Atlit, Beersheba, Hadera, Haifa, Holon, Jerusalem, Kfar Saba, Kiryat Motzkin, Netanya, Petah Tikva, Ramat Gan, Rehovot, Sakhnin, Tel Aviv
Életkor
18 év and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
3. fázisTaking people
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Where
Beer Jacob, Beersheba, Haifa, Jerusalem, Petah Tikva
Életkor
6 év to 11 év
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07817875 · EU 2025-522020-27-00
3. fázisNot yet taking people in Izrael
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Ashdod, Beer Yaakov, Hadera, Haifa, Holon, Jerusalem, Kfar Saba, Petah Tikva, Safed, Tel HaShomer, Tiberias
Életkor
45 év to 64 év
People
8500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
3. fázisTaking people
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Where
Haifa, Jerusalem, Petah Tikva, Tsrifin
Életkor
8 év to 18 év
People
460 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00
3. fázisTaking people
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Where
Afula, Beersheba, Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
Életkor
12 év to 17 év
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06439277
3. fázisTaking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Afula, Ashdod, Beersheba, Beer Yaakov, Hadera, Haifa, Holon, Jerusalem, Safed
Életkor
18 év and over
People
5610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
No phaseTaking people
The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment
Where
Rehovot
Életkor
18 év to 65 év
People
200
Run by
Weizmann Institute of Science
See details and how to joinNCT06681246
No phaseTaking people
Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide
Where
Jerusalem, Ramat Gan
Életkor
65 év and over
People
60
Run by
Sheba Medical Center
See details and how to joinNCT06497595
No phaseNot yet taking people in Izrael
Metabolic Changes Associated With Weight Gain After Treatment of Achalasia
Where
Jerusalem, Tsrifin
Életkor
18 év and over
People
30
Run by
Assaf-Harofeh Medical Center
See details and how to joinNCT07334639
No phaseTaking people
Tailored One Anastomosis Gastric Bypass
Where
Tel Aviv
Életkor
18 év and over
People
500
Run by
Tel-Aviv Sourasky Medical Center
See details and how to joinNCT06829381
No phaseNot yet taking people in Izrael
Plant vs Animal-based Protein Sources as an Anabolic and Metabolic-protective Options for SO in Older Adults
Where
Tel Aviv
Életkor
55 év and over
People
180
Run by
Tel-Aviv Sourasky Medical Center
See details and how to joinNCT07030738
4. fázisNot yet taking people in Izrael
Comparing High Versus Low Dose of Oxytocin, in Gravida Women With BMI 30 and Above Which Are Undergoing Induction of Labor
Where
Afula
People
130
Run by
HaEmek Medical Center, Israel
See details and how to joinNCT06990217
No phaseTaking people
Evaluating Family & Community-Based Interventions to Improve Treatment Adherence in Metabolic Health Among Negev Bedouins (EFIT-BED)
Where
Rahat
Életkor
18 év and over
People
170
Run by
Ariel University
See details and how to joinNCT06575465
No phaseTaking people
Database Maintenance for Bariatric Procedures
Where
Ramat Gan
People
5000
Run by
Sheba Medical Center
See details and how to joinNCT04040413